Cox-2 inhibitor painkillers "frequently" in adverse event top ten says UK agency

This material is from a 2005 investigation by Brian Deer for The Sunday Times of London into the painkiller Vioxx | Go to Vioxx index

The document below is a restricted report, titled "COx-2 selective inhibitors: European assessment of safety and efficacy - referral under Article 31 of 2001/83/EC", by the UK Medicines and Healthcare products Regulatory Agency submitted to a meeting of the British government's Committee on Safety of Medicines' sub-committee on pharmacovigilance held on April 29 2003

Notes: Redactions to this document are by the UK Medicines and Healthcare products Regulatory Agency on supply to Brian Deer under freedom of information law. Annexes may be available by emailing Brian Deer, but supply isn't guaranteed. Please support investigative journalism by linking to this page and/or crediting this website: briandeer.com